Emerging Trends in the Antibody Drug Conjugate Market
The Antibody Drug Conjugate Market is evolving rapidly as novel ADC designs address unmet medical needs in oncology. Advances in linker chemistry and cytotoxic payloads have enhanced the precision of these therapies, allowing them to selectively attack cancer cells while reducing off-target toxicity. The increasing prevalence of targeted therapies in clinical trials highlights the growing focus...
0 Commenti 0 condivisioni 207 Views 0 Anteprima